National Center for Health Statistics estimates drug overdoses killed 64,070 people in the US last year, a rise of 21% from 2015

Quick Read

A year ago, Maine was one of the first states to set limits on opioid prescriptions. The goal in capping the dose of prescription painkillers a patient could get was to stem the flow of opioids that are fueling a nationwide epidemic of abuse

Quick Read

A nationwide survey shows that postpartum nurses often fail to warn mothers about potentially life-threatening complications, mainly because they need more education themselves

Quick Read

The opioid epidemic could kill as many as 650,000 people in the next decade. Here’s how it got so bad

Quick Read

The agency is proposing new rules that could save millions of lives

Quick Read

Too often, people return home from the hospital only to find themselves heading back soon after. Sometimes the need arises because, despite the best care, it is difficult to slow the progression of disease. But other times, it’s because we in the health care system fail to communicate, coordinate and orchestrate the care that people need to successfully make the transition from hospital to home

Quick Read

Nolan and Jack Willis and just 10 other boys took part in a clinical trial that led to the approval last fall of the very first drug to treat their rare, deadly muscle disease. Now the Willis boys are again test cases as a different type of medical question comes to the fore: whether insurers will cover the controversial drug, Exondys 51, which can cost more than $1 million a year even though it’s still unclear if it works

Quick Read

Review concludes drugs, costing £30k per patient, hailed as cure for potentially fatal liver disease may clear virus from blood, but there is no evidence they prevent harm or save lives

Quick Read